Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Market Cap	152.89M
Revenue (ttm)	211.93M -1.1%
Net Income	13.52M +8.3%
EPS	0.04 +8.2%
Shares Out	223.19M
PE Ratio	15.26
Forward PE	n/a
Dividend	0.03 (3.65%)
Ex-Dividend Date	Jan 16, 2026

Volume	10,000
Average Volume	170,945
Open	0.6850
Previous Close	0.6900
Day's Range	0.6850 - 0.6850
52-Week Range	0.5800 - 0.7350
Beta	0.20
RSI	49.62
Earnings Date	Feb 20, 2026

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services. It also conducts research and development in biotechnology; distributes human healthcare and related products; wholesales and distributes pharmaceu...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 205
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: RHONEMA

Financial Performance

In 2024, Rhone Ma Holdings Berhad's revenue was 211.41 million, an increase of 4.17% compared to the previous year's 202.93 million. Earnings were 12.31 million, an increase of 1.87%.